Skip to search formSkip to main contentSkip to account menu

Loxapine Succinate

Known as: 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Succinate(1:1), Loxapinsuccinate, Butanedioic Acid, compound with 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine(1:1) 
The succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent with antiemetic, sedative, anticholinergic, and antiadrenergic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Thin-layer chromatography (TLC) was used to confirm the alleged ingestion of Loxitane (loxapine succinate) by a 20-month-old… 
1982
1982
AMOXAPINE is a new antidepressant approved for marketing in the United States just over a year ago. It is structurally similar to… 
Review
1980
Review
1980
138 acutely ill schizophrenic patients were treated with oral loxapine succinate for up to 4 weeks in nine studies, all of which… 
1979
1979
1. A g.l.c. method for quantitative determination of loxapine (2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine), in… 
1979
1979
Commercialized in the U.S.A. a few years ago, the loxapine succinate appears to be interesting among neuroleptic compounds. Used… 
1976
1976
Thirty-one chronic psychotic patients were treated with loxapine succinate, 20 for two years and eleven for one year, in order to… 
1975
1975
Therapeutic efficacy and safety of loxapine succinate (LOX) and trifluoperazine hydrochloride were compared by means of a… 
1975
1975
Therapeutic efficacy and safety of loxapine succinate (LOX) and trifluoperazine hydrochloride were compared by means of a…